Expensive Hepatitis C Cure ─ Georgia Decides Who Gets It, Who Doesn't

There’s a new drug on the market that’s up to 99 percent effective at curing hepatitis C, an often deadly liver virus. The drug is known as “V-pak.”

Some Georgians will get it.

But thousands of HIV-positive Georgians, who also have hepatitis C, won't.

The reason? Cost.


Read more and listen to the podcast here....